HomeALRN • NASDAQ
add
Aileron Therapeutics Inc
Previous close
$3.46
Day range
$3.39 - $3.69
Year range
$1.01 - $7.42
Market cap
76.91M USD
Avg Volume
81.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.04M | 334.57% |
Net income | -8.94M | -400.39% |
Net profit margin | — | — |
Earnings per share | -0.45 | -8.99% |
EBITDA | -9.04M | -336.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.92M | 60.38% |
Total assets | 109.40M | 681.93% |
Total liabilities | 8.38M | 600.00% |
Total equity | 101.02M | — |
Shares outstanding | 21.67M | — |
Price to book | 1.34 | — |
Return on assets | -21.67% | — |
Return on capital | -23.50% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -8.94M | -400.39% |
Cash from operations | -8.39M | -169.22% |
Cash from investing | — | — |
Cash from financing | 18.26M | — |
Net change in cash | 9.88M | 83.41% |
Free cash flow | -5.43M | -110.88% |
About
Founded
2001
Headquarters
Website
Employees
15